$13.29
+0.04 (+0.30%)
As of May 9, 1:29 AM ET ·
Analyst Consensus
Strong Sell
16
Analysts
High
Coverage
Buy 1 6%
Hold 6 38%
Sell 9 56%
Price Target
Analyst Price Target +580.2% upside
Low Target $73.92
Average Target $90.40
High Target $125.40
Current Price $13.29
Current
$13.29
Target
$90.40
$73.92 $90.40 avg $125.40
Scenario Analysis
Bear Case
$73.92
456.2%
Low target
Base Case
$90.40
+580.2%
Avg target
Bull Case
$125.40
+843.6%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$13.44
-1.1% from high
52-Week Low
$5.69
+133.6% from low
50-Day SMA
$7.87
+68.9% vs SMA
200-Day SMA
$8.85
+50.2% vs SMA
RSI (14)
32.1
Neutral
Target vs 52W High
$90.40
+572.6% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%